Ludwig Enterprises, Inc. operates as a medical technology holding company. It engages in the developing of messenger ribonucleic acid (mRNA) genetic testing kits to treat inflammatory genetic markers associated with chronic diseases. The company was founded in 2006 and is based in Sparks, Nevada.
Stock data | 2024 | Change |
---|---|---|
Price | $0.175 | N/A |
Market Cap | $56.62M | N/A |
Shares Outstanding | 323.57M | N/A |
Employees | 1.00 | N/A |